Rafal M. Wojciechowski

Bydgoszcz, KP, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

B cell depletion and BAFF receptor blockade with ianalumab (VAY736) for the treatment of moderate-to-severe systemic lupus erythematosus: a phase 2 randomised, double-blind, placebo-controlled trial with subsequent open-label treatment.

B cell depletion and BAFF receptor blockade with ianalumab (VAY736) for the treatment of moderate-to-severe systemic lupus erythematosus: a phase 2 randomised, double-blind, placebo-controlled trial with subsequent open-label treatment.

Journal: Annals of the rheumatic diseases

Published: July 15, 2025

Efficacy and Safety of Biosimilar CT-P47 Versus Reference Tocilizumab: 1-Year Results of a Randomised, Active-Controlled, Double-Blind, Phase III Study in Patients with Rheumatoid Arthritis.

Efficacy and Safety of Biosimilar CT-P47 Versus Reference Tocilizumab: 1-Year Results of a Randomised, Active-Controlled, Double-Blind, Phase III Study in Patients with Rheumatoid Arthritis.

Journal: Clinical drug investigation

Published: May 28, 2025

The role of magnetic resonance imaging in monitoring patients with axial spondyloarthritis.

The role of magnetic resonance imaging in monitoring patients with axial spondyloarthritis.

Journal: Reumatologia

Published: November 26, 2024

CT-Based Evaluation of Volumetric Posterior Pelvic Bone Density with Implications for the Percutaneous Screw Fixation of the Sacroiliac Joint.

CT-Based Evaluation of Volumetric Posterior Pelvic Bone Density with Implications for the Percutaneous Screw Fixation of the Sacroiliac Joint.

Journal: Journal of clinical medicine

Published: August 14, 2024

Osteoporosis in axial radiographic spondyloarthritis: diagnostic limitations of bone mineral density and the need for comprehensive fracture risk assessment.

Osteoporosis in axial radiographic spondyloarthritis: diagnostic limitations of bone mineral density and the need for comprehensive fracture risk assessment.

Journal: Reumatologia

Published: July 28, 2024

Efficacy and safety of CT-P47 versus reference tocilizumab: 32-week results of a randomised, active-controlled, double-blind, phase III study in patients with rheumatoid arthritis, including 8 weeks of switching data from reference tocilizumab to CT-P47.

Efficacy and safety of CT-P47 versus reference tocilizumab: 32-week results of a randomised, active-controlled, double-blind, phase III study in patients with rheumatoid arthritis, including 8 weeks of switching data from reference tocilizumab to CT-P47.

Journal: RMD open

Published: May 10, 2024

Coupled Field Analysis of Phenomena in Hybrid Excited Magnetorheological Fluid Brake.

Coupled Field Analysis of Phenomena in Hybrid Excited Magnetorheological Fluid Brake.

Journal: Sensors (Basel, Switzerland)

Published: November 28, 2022

Efficacy and safety of switching from reference adalimumab to CT-P17 (100 mg/ml): 52-week randomized, double-blind study in rheumatoid arthritis.

Efficacy and safety of switching from reference adalimumab to CT-P17 (100 mg/ml): 52-week randomized, double-blind study in rheumatoid arthritis.

Journal: Rheumatology (Oxford, England)

Published: March 08, 2021

Efficacy and safety of biosimilar CT-P17 versus reference adalimumab in subjects with rheumatoid arthritis: 24-week results from a randomized study.

Efficacy and safety of biosimilar CT-P17 versus reference adalimumab in subjects with rheumatoid arthritis: 24-week results from a randomized study.

Journal: Arthritis research & therapy

Published: September 23, 2020

Application of Multi-Branch Cauer Circuits in the Analysis of Electromagnetic Transducers Used in Wireless Transfer Power Systems.

Application of Multi-Branch Cauer Circuits in the Analysis of Electromagnetic Transducers Used in Wireless Transfer Power Systems.

Journal: Sensors (Basel, Switzerland)

Published: February 27, 2020

Comparative clinical efficacy and safety of the proposed biosimilar ABP 710 with infliximab reference product in patients with rheumatoid arthritis.

Comparative clinical efficacy and safety of the proposed biosimilar ABP 710 with infliximab reference product in patients with rheumatoid arthritis.

Journal: Arthritis research & therapy

Published: October 18, 2019

The role of ultrasonography in monitoring long-standing rheumatoid arthritis: a pilot study.

The role of ultrasonography in monitoring long-standing rheumatoid arthritis: a pilot study.

Journal: Reumatologia

Published: July 17, 2017

Showing 1-12 of 13

Last Updated: 09/26/2026